The life sciences industry is formulating the future — and reinventing itself in the process.
Investor interest, technological advancements and collaborations are driving innovation. But the path to innovation is not without challenges. As they pursue drug development, growth-stage biotechs, med device companies and large pharmaceuticals alike will face financial risk, changing regulations, supply chain disruption and uncertain ROI.
BDO’s Life Sciences consulting practice offers a full suite of tax, assurance and advisory services to help clients thrive in this evolving space. Our deep industry experience makes us a valuable catalyst for our clients’ success. Our BioProcess Technology Group (BPTG) provides pharmaceutical consulting and technical support with Chemistry, Manufacturing and Controls (CMC) across each stage of the drug development process, from pre-clinical research through commercialization. We also assist with ESG, including helping facilities become LEED certified and documenting clinical trial transparency.
In life sciences, scientific and technological advancement creates opportunity: bringing investor interest, growth potential and competitive advantage. BDO stands ready to assist with technical development, risk management, revenue optimization and accelerating speed to market.
We serve a broad range of life science clients at every lifecycle stage, including:
Biotechnology
Pharmaceuticals
Medical Device and Medical Technology Manufacturers
Contract Research Organizations and Labs
Contract Development and Manufacturing Organizations
Life Sciences Insights
Explore our most recent resources and thought leadership.
FEATURED
Article
2023 BDO Life Sciences CFO Outlook Survey
January 30, 2023
Article
2023 BDO Life Sciences CFO Outlook Survey
January 30, 2023
Read the 2023 BDO Life Sciences CFO Outlook Survey to see what the industry’s CFOs are doing to conserve cash — and what those decisions could mean for your company going forward.
2023 will be about finding balance as the biotech industry adjusts to its new financial reality. Discover the latest updates in the industry in our Q1 Biotech Brief.
Blockchain for Your Life Sciences & Healthcare Organization
March 3, 2023
Article
Blockchain for Your Life Sciences & Healthcare Organization
March 3, 2023
Blockchain can be a game-changing technology for both life sciences and healthcare, as it offers opportunities for efficient collaboration, transparent data-sharing and enhanced security.
Whether you want to reduce reliance on one location, optimize and move your current locations, address shrinking operating margins, improve agility or support growth, BDO can help you achieve those goals.
The State of Outsourced Mammalian and Microbial Capacity
January 3, 2023
Article
The State of Outsourced Mammalian and Microbial Capacity
January 3, 2023
BDO’s bioTRAK database, which tracks supply and demand for biopharmaceutical manufacturing capacity, is showing that outsourcing in the industry isn’t going away anytime soon.
What we learned at Day 2 of BARDA’s 2022 Industry Day Conference
December 19, 2022
Article
What we learned at Day 2 of BARDA’s 2022 Industry Day Conference
December 19, 2022
For those in the Life Sciences space – check out Part Two of our series on key takeaways from the Biomedical Advanced Research and Development Authority (BARDA) Industry Day annual conference.
What we learned at BARDA’s 2022 Industry Day Conference
November 22, 2022
Article
What we learned at BARDA’s 2022 Industry Day Conference
November 22, 2022
Each year the Biomedical Advanced Research and Development Authority (BARDA) holds an annual Industry Day conference showcasing successful industry partnerships and providing insight into future federal interagency priorities to support product development to address public health threats. BARDA and their interagency partners provide nondilutive funding to support advanced research and development of medical countermeasures (MCMs).
Ask These Questions Before Pursuing an M&A Transaction
November 7, 2022
Article
Ask These Questions Before Pursuing an M&A Transaction
November 7, 2022
For life sciences companies, M&A and collaborations are a key strategy for growth, building product pipelines and getting products to market as quickly as possible.
Regulations in the European Union for the Use of Triton X-100 in the Pharmaceutical Industry
November 4, 2022
Article
Regulations in the European Union for the Use of Triton X-100 in the Pharmaceutical Industry
November 4, 2022
Today, most pharmaceutical companies developing new products and processes are avoiding the use of Triton X-100 and instead searching for alternative options.
BDO’s Healthcare and Life Sciences Data Protection Webinar Series
October 31, 2022
Article
BDO’s Healthcare and Life Sciences Data Protection Webinar Series
October 31, 2022
Join BDO’s Governance, Risk and Compliance team for a webinar series to learn more about how we help companies address their performance, regulatory compliance and governance challenges, which can impact leaders from the Board of Directors to the General Counsel and executive team.
Everything we do is rooted in our core purpose to help people thrive every day. It’s not only the right business thing to do; it’s the right human thing to do. This starts by putting our people at the center of our work and extends to how we treat and value our people, our clients and our communities. With a dedication to quality and a purpose-driven culture, BDO offers a powerful choice both for clients and those seeking rewarding professional careers.